METRONIDAZOLE

Course overview

METRONIDAZOLE IS ONE OF THE MAINSTAY DRUGS FOR THE TREATMENT OF ANAEROBIC BACTERIAL INFECTIONS, PROTOZOAL INFECTIONS, AND MICROAEROPHILIC BACTERIAL INFECTIONS. IT IS CYTOTOXIC TO FACULTATIVE ANAEROBIC MICROORGANISMS. IT IS USED TO TREAT INTESTINAL AMEBIASES, LIVER AMEBIASIS, BACTERIAL SEPTICEMIA, BONE AND JOINT INFECTIONS, MENINGITIS, BRAIN ABSCESS, ENDOCARDITIS, ENDOMETRITIS, BACTERIAL VAGINOSIS, INTRA-ABDOMINAL INFECTIONS, LOWER RESPIRATORY TRACT INFECTIONS, SKIN STRUCTURE INFECTIONS, AND SURGICAL PROPHYLAXIS COLORECTAL SURGERIES. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, CONTRAINDICATIONS, MONITORING, AND OTHER KEY FACTORS PERTINENT TO INTERPROFESSIONAL TEAM MEMBERS IN THE CARE OF PATIENTS BEING TREATED WITH THIS MEDICATION.